Kaya Limited · NSE:KAYA
Kaya — Investor Presentation (May 2024)
17 slides from Kaya's investor presentation, May 10, 2024
Slide 1: Kaya Holdings, Inc.
Kaya Holdings, Inc. OTCOB:KAYS Setting the Standard for tes, SACRED Psychedelic MY a Paese, Treatment MUSHROOM EXPLORATION COMPANY Centers @e KAVA HOWINGS © 2024 All Rights Reserved, Kaya Holdings, Inc.
Slide 2: Important Disclosure
Important Disclosure KAYS is planning execution of its stated business objectives in accordance with current understanding of state and local laws and federal enforcement policies and priorities as it relates to psychedelics and cannabis. Potential investors and shareholders are cautioned that KAYS
Slide 3: Morgan Stanley Report
Morgan Stanley Report Counterpoint Global Insights: Psychedelics July 2023 “.,.Psychedelics offer a fundamental change in how mental health disorders are treated...Depression is now one of the leading causes of disability, and the global cost to treat mental health illness is anticipated to reach $6
Slide 4: Psilocybin Service Center License
Health Service Center License ID: SC-bd26b0fe Name and Address Operational Name Address FOT OREGON 1, LLC (Trade Name: “The Sacred Mushroom’) 321 NW Glisan Street, suite 700 Portland, OR 97209 Multnomah Service Center License Information ‘Approved Date Applicants Entity Applicants 04/25/2024 Bryan A
Slide 5: Addressing a Mental Healthcare Crisis
Addressing a Mental Healthcare Crisis = 46,494,000 American adults (18%) battle an anxiety disorder such as Post Traumatic Stress Disorder, Panic Disorder, Obsessive Compulsive Disorder, and generalized anxiety disorder. = 24,538,500 American adults (9.5%) suffer from a depressive illness. = 17,306,
Slide 6: The Science of Psilocybin
Tae oacRe The Science of Psilocybin Growing evidence suggests that psychedelics act on the brain’s default network, or those regions of the brain that remain active when your brain is not engaged in active tasks. The default network provides a “framework” for the brain's activity, providing structur
Slide 7: The Opportunity
The Opportunity According to research group Fact.MR, the U.S. psychedelic pharmaceutical market was valued at $487.5 million in 2021 and is expected to grow at a CAGR of 7.8% from 2022-2031, for a market valued at $1.13 billion in 2031 According to research group Grand View Research, the U.S. psyche
Slide 8: The Facility
JHEst* SACRED USHROO The Facility 11,000 square feet on the top floor of Portland's historic Falcon Building © 2024 All Rights Reserved, Kaya Holdings, Inc.
Slide 9: The Facility
Te SACRED USHROO The Facility
Slide 10: Facility Features
Tae oacRe MUSHROOM Facility Features © On Gre) > cs nigel GUS Private rooms tor Group session Activity Zones Microdosing On Site individual sessions sheas massage chairs, listening Cafe cultivation posts, journaling stations, painting and yoga sections The Company has a proprietary treatment process
Slide 11: Treatment Philosophy
JHE ACRED TuROO MY Treatment Philosophy SC Vu! ‘ S e 4 Accessibility Sustainability Integration Pricing structures and treatment Microdosing and small dosing Treatment follow up options programs that broaden the base of options for people seeking lower include Scared Mushroom people able to seek hea
Slide 12: Concept Innovations
Concept Innovations Customized Room Options The Company has created a way for patients to customize their in-facility room by selecting from options for sight, sound, and scent. §$§ Micro-Dosing Cafe Microdosing psilocybin can be experienced in a café setting, permitting the participant to consume t
Slide 13: Business Model
Tae oacRe MUSHROOM $f? er aR Biya In-Facility Treatments In-facility psilocybin experiences as permitted by law, both group and individual, with an emphasis on accommodating groups. Business Model gS) Integration Services After treatment services and programs to sustain treatment benefits. © 2024 Al
Slide 14: Marketing
Tae oacRe MUSHROOM @ ) -j 8 Digital Marketing online, landing pages, SEO, influencers and other tactics to raise awareness among interested groups. Marketing nar teh Use of community and advocacy groups to facilitate treatment. © 2024 Alll Rights Reserved, Kaya Holdings, Inc. x % International Partn
Slide 15: Kaya Holdings
@e KAVA HOUWINGS mMip CARE v Fully reporting publicly traded company (OTCOB:KAYS). ¥ Cannabis retail operations in Oregon since 2014. ¥ Cannabis cultivation and processing operations under development in Greece. v Expanding operations into natural vertical - Psychedelics. © 2023 All Rights Reserved,
Slide 16: Conclusion
Conclusion Bringing research supported treatments to people desperately seeking relief. Compelling treatment center innovations and experience differentiators. Operating experience in highly regulated environments. Positioned for partnerships with select pharmaceutical companies. Entry into the psyc
Slide 17: The Sacred Mushroom
THE #?* SACRED Vie HROO MUSHROOM EXPLORATION COMPANY An innovative “mind care” company offering research-based therapies to people challenged by treatment resistant mental health disorders. m KAVA HOWINGS © 2024 Alll Rights Re